Sickle cell anaemia: Current therapies

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 151-154

  Vermylen, Christiane ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN; FLUDARABINE; HYDROXYUREA; RAPAMYCIN; THYMOCYTE ANTIBODY;

BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR HEMOLYSIS; IRON CHELATION; IRON OVERLOAD; MYELOABLATIVE CONDITIONING; NONHUMAN; PHLEBOTOMY; REGULATORY T LYMPHOCYTE; REVIEW; SICKLE CELL ANEMIA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALLOGRAFTS; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYDROXYUREA; IRON CHELATING AGENTS; MALE;

EID: 84886640530     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.07.018     Document Type: Review

References (17)

1. Lebensburger J.D., Miller S.T., Howard T.H., et al. Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study. Pediatr Blood Cancer 2012, 59:675-678.
2. Wang C.R., Ware R.E., Miller S.T., et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). The Lancet 2011, 377:1663-1672.
3. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
4. Hsieh M.M., Fitzhugh C.D., Tisdale J.F. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 2011, 118(5):1197-1207.
5. Fitzhugh C.D., Lauder N., Jonassaint J.C., et al. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell didease. Am J Hematol 2010, 85:36-40.
6. Rogers Z.R., Wang W.C., Luo Z., et al. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG trial. Blood 2011, 117:2614-2617.
7. McCarville M.B., Luo Z., Huang X., et al. Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial. AJR 2001, 196:1399-1404.
8. Alvarez O., Miller S.T., Wang W., et al. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr Blood Cancer 2012, 59:668-674.
9. Kwiatkowski J.L., Yim E., Miller S., Adams R.J. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood cancer 2011, 56:777-782.
10. Adams R.J., Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353:2769-2778.
11. Ware R.E., Helms R.W. Stroke With Transfusions Changing to Hydroxyurea (SWITCH). Blood 2012, 119:3925-3932.
12. Locatelli F., Pagliara D. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease. Pediatr Blood Cancer 2012, 59:372-376.
13. Vermylen C., Cornu G., Ferster A., et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow transplant 1998, 22:1-6.
14. Bernaudin F., Socie G., Kuentz M., et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007, 110(7):2749-2756.
15. Iannone R., Casella J.F., Fuchs E.J., et al. Results of minimally toxic nonmyeloabaltive transplantation in patients with sickle cell anaemia and beta-thalassemia. Biol Blood Marrow Transplant 2003, 9(8):519-528.
16. Quinn C.T., Rogers Z.R., McCavit T.L., Buchanan G.R. Improved survival of children and adolescents with sickle cell disease. Blood 2012, 115(17):3447-3452.
17. Gladwin M.T., Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol 2012, 59:1123-1133.